Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eri Yamabe
Institution:
Osaka International Cancer Institute
Observed institution:
Osaka International Cancer Institute
ORCID:
0009-0006-9788-275X
Observed ORCID:
0009-0006-9788-275X
OpenAlex ID:
A5116289290
Preoperative prediction of the need for postoperative adjuvant therapy in stage IB cervical cancer using tumor size measured on magnetic resonance imaging and serum squamous cell carcinoma antigen levels
2026
·
Michihide Maeda
, Miho Kitai
, et al.
·
AJOG Global Reports
·
1
Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology
2025
·
Eri Yamabe
, Hironori Yamamoto
, et al.
·
Gynecologic Oncology Reports
·
1
Complete remission of small cell neuroendocrine carcinoma of the cervix treated with chemotherapy of paclitaxel, carboplatin, bevacizumab and pembrolizumab: A case report
2026
·
Reisa Kakubari
, Yui Nonokawa
, et al.
·
Gynecologic Oncology Reports
A retrospective analysis of risk-reducing salpingo-oophorectomy performed in women diagnosed with hereditary breast and ovarian cancer at our institution
2026
·
Yusaku Shimizu
, Miho Kitai
, et al.
·
Hereditary Cancer in Clinical Practice
Evaluating The Real-World Efficacy And Safety Of Pembrolizumab Combination Therapy In Advanced Recurrent Cervical Cancer: Insights From A Single-Center Study
2025
·
Miho Kitai
, Yusaku Shimizu
, et al.
·
International Journal of Gynecological Cancer
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type